Current Month 2011
Article Features
  A Form of Small Pox Virus Shows Potential for Treating Triple-Negative Breast Cancer
A Simple Blood Test Could Be Used to Detect Breast Cancer
Aggressive Cancer Exploits MYC Oncogene to Amplify Global Gene Activity
Are Too Few Women Being Offered Breast-Conserving Treatment?
Biological Markers Increase Clinical Trial Success Rate of New Breast Cancer Drugs
Breast Cancer Recurrence Defined by Hormone Receptor Status
Breast Cancer Treatment Brings Sexual Difficulties for Postmenopausal Women
Cell Death Discovery Suggests New Ways to Protect Female Fertility
Cloned Receptor Paves Way for New Breast and Prostate Cancer Treatment
Disparity in Breast Cancer Between Black and White Women Can Be Eliminated by Regular Screening
Exposing Cancer’s Lethal Couriers
Extending Trastuzumab for 2 years Does Not Significantly Improve Outcomes Versus 1 Year
First Comprehensive Review of European Breast Cancer Screening Programs Finds Benefits Outweigh Harm
Images Reveal Potential for NIR Imaging to Detect Success of Breast Reconstruction
Lack of Oxygen in Cancer Cells Leads to Growth and Metastasis
LIFR Protein Suppresses Breast Cancer Metastasis
New Insights on Control of Pituitary Hormone Outside of Brain Has Implications for Breast Cancer
Optical Mammography Sheds New Light on Breast Cancer
PARP Inhibitors May Have Clinical Utility in HER2-Positive Breast Cancers
PHARE Trial Results Comparing 6 to 12 Months of Trastuzumab in Adjuvant Early Breast Cancer
Preoperative Needle Breast Biopsies Can Lead to Improved Treatment Outcomes
Researchers Develop Blood Test That Accurately Detects Early Stages of Lung, Breast Cancer in Humans
Scientists Lead Cancer Genome Analysis of Breast Cancer
Severe Hunger Increases Breast Cancer Risk in War Survivors
Study Finds Least Aggressive Form of Breast Cancer Still Poses Risk Years Later
Study Links Breast Cancer Risk to Early-Life Diet and Metabolic Syndrome
Tissue Around Tumor Holds Key to Fighting Triple Negative Breast Cancer


Lack of Oxygen in Cancer Cells Leads to Growth and Metastasis

It seems as if a tumor deprived of oxygen would shrink. However, numerous studies have shown that tumor hypoxia, in which portions of the tumor have significantly low oxygen concentrations, is in fact linked with more aggressive tumor behavior and poorer prognosis. It's as if rather than succumbing to gently hypoxic conditions, the lack of oxygen commonly created as a tumor outgrows its blood supply signals a tumor to grow and metastasize in search of new oxygen sources – for example, hypoxic bladder cancers are likely to metastasize to the lungs, which is frequently deadly.

A University of Colorado Cancer Center study published in the journal Cancer Research details a mechanism by which these hypoxic conditions create aggressive cancer, with possible treatment implications for cancers including breast, ovarian, colorectal, pancreatic, prostate, bladder and other cancers.

"We've known that the protein HIF-1a is overexpressed in hypoxic tumors. And we've known that the cancer stem cell marker CD24 is overexpressed in many tumors. This study shows a link between the two – the HIF-1a of hypoxia creates the overexpression of CD24. And it's this CD24 that creates a tumor's aggressive characteristics of growth and metastasis," says Dan Theodorescu, MD, PhD, director of the University of Colorado Cancer Center and the paper's senior author.

Outgrowing the blood supply leads to tumor hypoxia, which leads to overexpression of HIF-1a, which signals the production of CD24, which makes tumors grow and metastasize. In addition to aggression, CD24 has also been shown to confer resistance to chemotherapy, allowing this small population of cells to regrow the tumor once chemotherapy ends, leading to relapse and disease progression.

"Now imagine we target CD24," Theodorescu says. "Either by removing a cell's ability to make CD24 or by killing cells marked by this protein, it's likely we could disarm this most dangerous population of cells."

Read More of the Main Article

 
Visit the Ezine


Visit the BreastCenter

Visit the Quality Corner
Avon Breast Cancer Crusade - AVON the company for women

  This website is supported in part by an unrestricted educational grant provided by Avon